BlackRock Advisors’s THERAGENICS CORP TGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2013
Q4
Sell
-5,558
Closed -$12K 3708
2013
Q3
$12K Hold
5,558
﹤0.01% 3434
2013
Q2
$12K Buy
+5,558
New +$9.95K ﹤0.01% 3382

BlackRock Advisors's TGX Position: Q4 2013 in Review

BlackRock Advisors sold out of THERAGENICS CORP (TGX) in Q4 2013, closing a stake of 5,558 shares — an estimated $12K sold.

BlackRock Advisors first reported a position in TGX in Q2 2013 and held it in 2 quarters. The position peaked at $12K in Q3 2013. 0 funds tracked by Wall St. Rank hold TGX as of Q4 2013.

  • BlackRock Advisors reported no remaining THERAGENICS CORP position as of Q4 2013 after selling out during the quarter.
  • BlackRock Advisors sold 5,558 THERAGENICS CORP shares in Q4 2013, an estimated $12K.
  • BlackRock Advisors first reported a position in THERAGENICS CORP in Q2 2013 and held it in 2 quarters.
  • BlackRock Advisors's THERAGENICS CORP position peaked at $12K in Q3 2013.
  • 0 funds tracked by Wall St. Rank held THERAGENICS CORP as of Q4 2013.

Based on BlackRock Advisors's 13F filing for Q4 2013, filed 12 Feb 2014.